Remove 2013 Remove Compounding Remove Dosage Remove Insurance Coverage
article thumbnail

MTHFR, Hashimoto’s and Nutrients

The Thyroid Pharmacist

I first started taking methylation support in 2013, and I attribute proper methylation support to my remission from Hashimoto’s symptoms. However, some may be concerned with this genetic information getting reported on insurance or to employers. Some individuals may feel anxious if they start high-dose methylation support too quickly.

Insurance 105
article thumbnail

Top Performing Drug – Enbrel (June Edition)

PharmaShots

The co-promotion collaboration agreement between the two companies in the United States and Canada expired on October 31, 2013. Consistent with prior periods, Enbrel continued to lose market share, and this decline was compounded by a reduction in the growth rate of the rheumatology market as a result of COVID-19.